Old and new insights in the treatment of thyroid carcinoma

Journal of Thyroid Research

Volumn 2010, Issue , 2010, Pages

  Blesa, Joan Manel Gasent ^a   Pulido, Enrique Grande ^b   Pulla, Mariano Provencio ^c   Candel, Vicente Alberola ^d   Canales, Juan Bautista Laforga ^a   Arrom, Miguel Grimalt ^e   Rico, Patricia Martin ^a  

^a Hospital de Dénia   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d HOSPITAL ARNAU DE VILANOVA   (Spain)

^e Hospital de Levante   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054755868     PISSN: 20908067     EISSN: 20420072     Source Type: Journal    
DOI: 10.4061/2010/279468     Document Type: Review

References (146)

1. I. D. Hay, "Papillary thyroid carcinoma", Endocrinology and Metabolism Clinics of North America, vol. 19, no. 3, pp. 545-576, 1990. (Pubitemid 20282656)
2. J.-D. Lin, T.-C. Chao, B.-Y. Huang, S.-T. Chen, H.-Y. Chang, and C. Hsueh, "Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology", Thyroid, vol. 15, no. 7, pp. 708-717, 2005. (Pubitemid 41117524)
3. M. T. Rojeski and H. Gharib, "Nodular thyroid disease. Evaluation and management", New England Journal of Medicine, vol. 313, no. 7, pp. 428-436, 1985. (Pubitemid 15014039)
4. E. L. Mazzaferri, "Management of a solitary thyroid nodule", New England Journal of Medicine, vol. 328, no. 8, pp. 553-559, 1993. (Pubitemid 23053833)
5. S. R. Tollin, G. M. Mery, N. Jelveh, et al., "The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter", Thyroid, vol. 10, no. 3, pp. 235-241, 2000. (Pubitemid 30202410)
6. A. Liebeskind, A. G. Sikora, A. Komisar, D. Slavit, and K. Fried, "Rates of malignancy in incidentally discovered thyroid nodules evaluated with sonography and fine-needle aspiration", Journal of Ultrasound in Medicine, vol. 24, no. 5, pp. 629-634, 2005. (Pubitemid 40577677)
7. C. Sklar, J. Whitton, A. Mertens, et al., "Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the childhood cancer survivor study", Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 9, pp. 3227-3232, 2000.
8. M. D. Tronko, G. R. Howe, T. I. Bogdanova, et al., "A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening", Journal of the National Cancer Institute, vol. 98, no. 13, pp. 897-903, 2006. (Pubitemid 44018919)
9. D. Handkiewcz-Junak, T. Banasik, Z. Kolosza, et al., "Risk of malignant tumors in first-degree relatives of patients with differentiated thyroid cancer - a hospital based study", Neoplasma, vol. 53, no. 1, pp. 67-72, 2006. (Pubitemid 43206942)
10. Thyroid Carcinoma Task Force, "AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology", Endocrine Practice, vol. 7, no. 3, pp. 202-220, 2001.
11. S. P. Hodak and K. D. Burman, "Editorial: the calcitonin conundrum-is it time for routine measurement of serum calcitonin in patients with thyroid nodules?" Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 2, pp. 511-514, 2004. (Pubitemid 38269850)
12. I. D. Hay, C. S. Grant, W. F. Taylor, and W. M. McConahey, "Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system", Surgery, vol. 102, no. 6, pp. 1088-1095, 1987. (Pubitemid 18010757)
13. B. Cady and R. Rossi, "An expanded view of risk-group definition in differentiated thyroid carcinoma", Surgery, vol. 104, no. 6, pp. 947-953, 1988. (Pubitemid 19011971)
14. D. P. Byar, S. B. Green, P. Dor, et al., "A prognostic index for thyroid carcinoma. A study of the E. O. R. T. C. Thyroid Cancer Cooperative Group", European Journal of Cancer and Clinical Oncology, vol. 15, no. 8, pp. 1033-1041, 1979. (Pubitemid 9254743)
15. S. I. Sherman, J. D. Brierley, M. Sperling, et al., "Prospective multicenter study of thyroid carcinoma treatment initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group", Cancer, vol. 83, no. 5, pp. 1012-1021, 1998. (Pubitemid 28401936)
16. I. D. Hay, E. J. Bergstralh, J. R. Goellner, J. R. Ebersold, and C. S. Grant, "Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989", Surgery, vol. 114, no. 6, pp. 1050-1058, 1993. (Pubitemid 24004722)
17. S. A. Hundahl, I. D. Fleming, A. M. Fremgen, and H. R. Menck, "A National Cancer Data Base report on 53, 856 cases of thyroid carcinoma treated in the U. S., 1985-1995", Cancer, vol. 83, no. 12, pp. 2638-2648, 1998. (Pubitemid 29019586)
18. E. T. Kimura, M. N. Nikiforova, Z. Zhu, J. A. Knauf, Y. E. Nikiforov, and J. A. Fagin, "High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma", Cancer Research, vol. 63, no. 7, pp. 1454-1457, 2003. (Pubitemid 36373628)
19. Y. Indo, S. Mardy, M. Tsuruta, et al., "Structure and organization of the human trka gene encoding a high affinity receptor for nerve growth factor", Japanese Journal of Human Genetics, vol. 42, no. 2, pp. 343-351, 1997.
20. I. Bongarzone, P. Vigneri, L. Mariani, P. Collini, S. Pilotti, and M. A. Pierotti, "RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features", Clinical Cancer Research, vol. 4, no. 1, pp. 223-228, 1998. (Pubitemid 28062900)
21. Y. E. Nikiforov, J. M. Rowland, K. E. Bove, H. Monforte-Munoz, and J. A. Fagin, "Distinct pattern of ret oncogene rearrangements in morphological variants of radiationinduced and sporadic thyroid papillary carcinomas in children", Cancer Research, vol. 57, no. 9, pp. 1690-1694, 1997. (Pubitemid 27199660)
22. Y. Cohen, M. Xing, E. Mambo, et al., "BRAF mutation in papillary thyroid carcinoma", Journal of the National Cancer Institute, vol. 95, no. 8, pp. 625-627, 2003. (Pubitemid 36553510)
23. Y. Cohen, E. Rosenbaum, D. P. Clark, et al., "Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules", Clinical Cancer Research, vol. 10, no. 8, pp. 2761-2765, 2004. (Pubitemid 38509152)
24. L. Fugazzola, D. Mannavola, V. Cirello, et al., "BRAF mutations in an Italian cohort of thyroid cancers", Clinical Endocrinology, vol. 61, no. 2, pp. 239-243, 2004. (Pubitemid 39093120)
25. C. Lupi, R. Giannini, C. Ugolini, et al., "Extensive clinical experience: association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma", Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 11, pp. 4085-4090, 2007. (Pubitemid 350074715)
26. M. Xing, W. H. Westra, R. P. Tufano, et al., "BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer", Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 12, pp. 6373-6379, 2005. (Pubitemid 41759286)
27. V. Vasko, S. Hu, G. Wu, et al., "High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes", Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 9, pp. 5265-5269, 2005. (Pubitemid 41262284)
28. J. Lima, V. Trovisco, P. Soares, et al., "BRAF mutations are not a major event in post-chernobyl childhood thyroid carcinomas", Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 9, pp. 4267-4271, 2004. (Pubitemid 39244424)
29. Z. Zhu, M. Gandhi, M. N. Nikiforova, A. H. Fischer, and Y. E. Nikiforov, "Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma: an unusually high prevalence of ras mutations", American Journal of Clinical Pathology, vol. 120, no. 1, pp. 71-77, 2003. (Pubitemid 37046372)
30. F. M. Giardiello, G. J. A. Offerhaus, D. H. Lee, et al., "Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis", Gut, vol. 34, no. 10, pp. 1394-1396, 1993. (Pubitemid 23293626)
31. F. Cetta, G. Chiappetta, R. M. Melillo, et al., "The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas", Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 3, pp. 1003-1006, 1998. (Pubitemid 28496483)
32. C. D. Malchoff and D. M. Malchoff, "Familial nonmedullary thyroid carcinoma", Seminars in Surgical Oncology, vol. 16, no. 1, pp. 16-18, 1999. (Pubitemid 28543958)
33. J. D. McKay, F. Lesueur, L. Jonard, et al., "Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21", American Journal of Human Genetics, vol. 69, no. 2, pp. 440-446, 2001. (Pubitemid 32695216)
34. T. Nishida, K. Nakao, and T. Hashimoto, "Local control in differentiated thyroid carcinoma with extrathyroidal invasion", American Journal of Surgery, vol. 179, no. 2, pp. 86-91, 2000. (Pubitemid 30204506)
35. J. P. Shah, T. R. Loree, D. Dharker, and E. W. Strong, "Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis", American Journal of Surgery, vol. 166, no. 4, pp. 331-335, 1993. (Pubitemid 24240981)
36. J. P. Shah, T. R. Loree, D. Dharker, E. W. Strong, C. Begg, and V. Vlamis, "Prognostic factors in differentiated carcinoma of the thyroid gland", The American Journal of Surgery, vol. 164, no. 6, pp. 658-661, 1992.
37. E. L. Mazzaferri and S. M. Jhiang, "Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer", American Journal of Medicine, vol. 97, no. 5, pp. 418-428, 1994. (Pubitemid 24345593)
38. R. L. Rossi, B. Cady, M. L. Silverman, M. S. Wool, and T. A. Horner, "Current results of conservative surgery for differentiated thyroid carcinoma", World Journal of Surgery, vol. 10, no. 4, pp. 612-622, 1986. (Pubitemid 16096418)
39. L. E. Sanders and B. Cady, "Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment", Archives of Surgery, vol. 133, no. 4, pp. 419-425, 1998. (Pubitemid 28193527)
40. I. D. Hay, C. S. Grant, E. J. Bergstralh, G. B. Thompson, J. A. Van Heerden, and J. R. Goellner, "Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES lowrisk papillary thyroid carcinoma?" Surgery, vol. 124, no. 6, pp. 958-966, 1998. (Pubitemid 28555179)
41. I. D. Hay, C. S. Grant, J. A. Van Heerden, J. R. Goellner, J. R. Ebersold, and E. J. Bergstralh, "Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period", Surgery, vol. 112, no. 6, pp. 1139-1147, 1992. (Pubitemid 23008243)
42. O. H. Clark, K. Levin, Q.-H. Zeng, F. S. Greenspan, and A. Siperstein, "Thyroid cancer: the case for total thyroidectomy", European Journal of Cancer and Clinical Oncology, vol. 24, no. 2, pp. 305-313, 1988. (Pubitemid 18051204)
43. W. B. Inabnet, "Surgical management of thyroid cancer", Endocrine Practice, vol. 6, no. 6, pp. 465-468, 2000.
44. D. S. Cooper, G. M. Doherty, B. R. Haugen, et al., "Management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, vol. 16, no. 2, pp. 109-141, 2006.
45. A. R. Shaha, J. P. Shah, and T. R. Loree, "Differentiated thyroid cancer presenting initially with distant metastasis", American Journal of Surgery, vol. 174, no. 5, pp. 474-476, 1997. (Pubitemid 27486006)
46. J.-D. Lin, M.-J. Huang, J.-H. Juang, et al., "Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases", Thyroid, vol. 9, no. 12, pp. 1227-1235, 1999. (Pubitemid 30038933)
47. W. Eichhorn, H. Tabler, R. Lippold, M. Lochmann, M. Schreckenberger, and P. Bartenstein, "Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution", Thyroid, vol. 13, no. 10, pp. 949-958, 2003. (Pubitemid 37351878)
48. T. G. Kroll, P. Sarraf, L. Pecciarini, et al., "PAX8-PPARγ1 fusion in oncogene human thyroid carcinoma", Science, vol. 289, no. 5483, pp. 1357-1360, 2000. (Pubitemid 30656054)
49. H. Karga, J.-K. Lee, A. L. Vickery Jr., A. Thor, R. D. Gaz, and J. L. Jameson, "Ras oncogene mutations in benign and malignant thyroid neoplasms", Journal of Clinical Endocrinology and Metabolism, vol. 73, no. 4, pp. 832-836, 1991. (Pubitemid 21921945)
50. A. R. Marques, C. Espadinha, A. L. Catarino, et al., "Expression of PAX8-PPARγ1 rearrangements in both follicular thyroid carcinomas and adenomas", Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 8, pp. 3947-3952, 2002. (Pubitemid 34879553)
51. L. S. Ward, G. Brenta, M. Medvedovic, and J. A. Fagin, "Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas", Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 2, pp. 525-530, 1998. (Pubitemid 28496534)
52. M. Xing, Y. Cohen, E. Mambo, et al., "Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis", Cancer Research, vol. 64, no. 5, pp. 1664-1668, 2004. (Pubitemid 38428687)
53. V. A. Li Volsi and Z. W. Baloch, "Use and abuse of frozen section in the diagnosis of follicular thyroid lesions", Endocrine Pathology, vol. 16, no. 4, pp. 285-294, 2005. (Pubitemid 43787105)
54. Z. W. Baloch and V. A. Li Volsi, "Fine-needle aspiration of thyroid nodules: past, present, and future", Endocrine Practice, vol. 10, no. 3, pp. 234-241, 2004.
55. R. L. Young, E. L. Mazzaferri, A. J. Rahe, and S. G. Dorfman, "Pure follicular thyroid carcinoma: impact of therapy in 214 patients", Journal of Nuclear Medicine, vol. 21, no. 8, pp. 733-737, 1980. (Pubitemid 10037036)
56. J. A. Van Heerden, I. D. Hay, J. R. Goellner, et al., "Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy", Surgery, vol. 112, no. 6, pp. 1130-1138, 1992. (Pubitemid 23008242)
57. B. Bell and E. L. Mazzaferri, "Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinoma. A case report and review of the literature", Digestive Diseases and Sciences, vol. 38, no. 1, pp. 185-190, 1993. (Pubitemid 23039474)
58. M. L. Carcangiu, G. Zampi, A. Pupi, A. Castagnoli, and J. V. Rosai, "A clinicopathologic study of 241 cases treated at the University of Florence, Italy", Cancer, vol. 55, no. 4, pp. 805-828, 1985. (Pubitemid 15173519)
59. M. Noguchi, H. Yamada, N. Ohta, et al., "Regional lymph node metastases in well-differentiated thyroid carcinoma", International Surgery, vol. 72, no. 2, pp. 100-103, 1987. (Pubitemid 17115151)
60. J. Harwood, O. H. Clark, and J. E. Dunphy, "Significance of lymph node metastasis in differentiated thyroid cancer", American Journal of Surgery, vol. 136, no. 1, pp. 107-112, 1978. (Pubitemid 8387088)
61. N. D. Goldman, J. U. Coniglio, and S. A. Falk, "Thyroid cancers I: papillary, follicular, and Hurthle cell", Otolaryngologic Clinics of North America, vol. 29, no. 4, pp. 593-609, 1996. (Pubitemid 26239268)
62. J. F. Henry, L. Gramatica, A. Denizot, A. Kvachenyuk, M. Puccini, and T. Defechereux, "Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma", Langenbeck's Archives of Surgery, vol. 383, no. 2, pp. 167-169, 1998. (Pubitemid 28442533)
63. A. R. Shaha, J. P. Shah, and T. R. Loree, "Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid", American Journal of Surgery, vol. 172, no. 6, pp. 692-694, 1996. (Pubitemid 27024782)
64. W. M. McConahey, I. D. Hay, L. B. Woolner, J. A. Van Heerden, and W. F. Taylor, "Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome", Mayo Clinic Proceedings, vol. 61, no. 12, pp. 978-996, 1986. (Pubitemid 17205209)
65. S. M. Wilson and G. E. Bock, "Carcinoma of the thyroid metastatic to lymph nodes of the neck", Archives of Surgery, vol. 102, no. 4, pp. 285-291, 1971.
66. D. Barbaro, G. Boni, G. Meucci, et al., "Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation", Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 9, pp. 4110-4115, 2003. (Pubitemid 37153707)
67. R. J. Robbins, S. M. Larson, N. Sinha, et al., "A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation", Journal of Nuclear Medicine, vol. 43, no. 11, pp. 1482-1488, 2002. (Pubitemid 35285874)
68. M. Luster, S. I. Sherman, M. C. Skarulis, et al., "Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma", European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 10, pp. 1371-1377, 2003. (Pubitemid 37247954)
69. F. Pacini, E. Molinaro, M. G. Castagna, et al., "Ablation of thyroid residues with 30 mCi 131I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal", Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 9, pp. 4063-4068, 2002.
70. M. Chianelli, V. Todino, F. M. Graziano, et al., "Lowactivity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rh TSH in low-risk patients", European Journal of Endocrinology, vol. 160, no. 3, pp. 431-436, 2009.
71. R. M. Tuttle, M. Brokhin, G. Omry, et al., "Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal", Journal of Nuclear Medicine, vol. 49, no. 5, pp. 764-770, 2008. (Pubitemid 351717542)
72. D. S. Cooper, G. M. Doherty, B. R. Haugen, et al., "Management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, vol. 16, no. 2, pp. 109-141, 2006.
73. D. Casara, D. Rubello, G. Saladini, et al., "Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables", Journal of Nuclear Medicine, vol. 34, no. 10, pp. 1626-1631, 1993. (Pubitemid 23295368)
74. M. Schlumberger, C. Challeton, F. De Vathaire, et al., "Radioactive Iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma", Journal of Nuclear Medicine, vol. 37, no. 4-6, pp. 598-605, 1996. (Pubitemid 126618447)
75. M. Luster, F. Lippi, B. Jarzab, et al., "rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review", Endocrine-Related Cancer, vol. 12, no. 1, pp. 49-64, 2005. (Pubitemid 40477087)
76. N. J. McGriff, G. Csako, L. Gourgiotis, C. G. Lori, F. Pucino, and N. J. Sarlis, "Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer", Annals of Medicine, vol. 34, no. 7-8, pp. 554-564, 2002. (Pubitemid 36113813)
77. R. W. Tsang, J. D. Brierley, W. J. Simpson, T. Panzarella, M. K. Gospodarowicz, and S. B. Sutcliffe, "The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma", Cancer, vol. 82, no. 2, pp. 375-388, 1998. (Pubitemid 28060256)
78. T.-H. Kim, D.-S. Yang, K.-Y. Jung, C.-Y. Kim, and M.-S. Choi, "Value of external irradiation for locally advanced papillary thyroid cancer", International Journal of Radiation Oncology, Biology, Physics, vol. 55, no. 4, pp. 1006-1012, 2003. (Pubitemid 36287004)
79. K. M. Meadows, R. J. Amdur, C. G. Morris, D. B. Villaret, E. L. Mazzaferri, and W. M. Mendenhall, "External beam radiotherapy for differentiated thyroid cancer", American Journal of Otolaryngology, vol. 27, no. 1, pp. 24-28, 2006. (Pubitemid 41797572)
80. J. D. Brierley and R. W. Tsang, "External-beam radiation therapy in the treatment of differentiated thyroid cancer", Seminars in Surgical Oncology, vol. 16, no. 1, pp. 42-49, 1999.
81. E. L. Mazzaferri and R. T. Kloos, "Current approaches to primary therapy for papillary and follicular thyroid cancer", Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 4, pp. 1447-1463, 2001. (Pubitemid 32374886)
82. H. Jadvar, I. R. McDougall, and G. M. Segall, "Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography", Nuclear Medicine Communications, vol. 19, no. 6, pp. 547-554, 1998. (Pubitemid 28319774)
83. L. A. Zimmer, B. McCook, C. Meltzer, et al., "Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer", Otolaryngology-Head and Neck Surgery, vol. 128, no. 2, pp. 178-184, 2003. (Pubitemid 36314864)
84. M. P. McDonald, L. E. Sanders, M. L. Silverman, H. S. Chan, and J. Buyske, "Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment", Surgery, vol. 120, no. 6, pp. 1000-1005, 1996. (Pubitemid 26418778)
85. 131I therapy in differentiated thyroid carcinoma: M. D. Anderson Hospital experience", Cancer, vol. 47, no. 4, pp. 664-671, 1981. (Pubitemid 11135861)
86. J. A. Gottlieb, C. S. Hill Jr., M. L. Ibanez, and R. L. Clark, "Chemotherapy of thyroid cancer. An evaluation of experience with 37 patients", Cancer, vol. 30, no. 3, pp. 848-853, 1972.
87. J. J. Ruegemer, I. D. Hay, E. J. Bergstralh, J. J. Ryan, K. P. Offord, and C. A. Gorman, "Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables", Journal of Clinical Endocrinology and Metabolism, vol. 67, no. 3, pp. 501-508, 1988.
88. M. L. Carcangiu, S. Bianchi, D. Savino, I. M. Voynick, and J. Rosai, "Follicular Hurthle cell tumors of the thyroid gland", Cancer, vol. 68, no. 9, pp. 1944-1953, 1991.
89. H. L. Evans and R. Vassilopoulou-Sellin, "Follicular and hurthle cell carcinomas of the thyroid: a comparative study", American Journal of Surgical Pathology, vol. 22, no. 12, pp. 1512-1520, 1998. (Pubitemid 28550646)
90. F. D. Moore and R. G. Dluhy, "Prophylactic thyroidectomy in MEN-2A - a stitch in time?" New England Journal of Medicine, vol. 353, no. 11, pp. 1162-1164, 2005. (Pubitemid 41317440)
91. C. H. Forrest, F. A. Frost, W. B. De Boer, D. V. Spagnolo, D. Whitaker, and G. F. Sterrett, "Medullary carcinoma of the thyroid: accuracy of diagnosis by fine-needle aspiration cytology", Cancer, vol. 84, no. 5, pp. 295-302, 1998. (Pubitemid 28516867)
92. R. Cohen, J.-M. Campos, C. Salaun, et al., "Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma", Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 2, pp. 919-922, 2000. (Pubitemid 32273687)
93. E. Modigliani, R. Cohen, J.-M. Campos, et al., "Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients", Clinical Endocrinology, vol. 48, no. 3, pp. 265-273, 1998. (Pubitemid 28137636)
94. A. V. Stepanas, N. A. Samaan, C. S. Hill Jr., and R. C. Hickey, "Medullary thyroid carcinoma. Importance of serial serum calcitonin measurement", Cancer, vol. 43, no. 3, pp. 825-837, 1979. (Pubitemid 9163608)
95. Q.-Y. Duh, J. J. Sancho, F. S. Greenspan, et al., "Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy", Archives of Surgery, vol. 124, no. 10, pp. 1206-1210, 1989. (Pubitemid 19250180)
96. J. F. Moley and M. K. De Benedetti, "Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection", Annals of Surgery, vol. 229, no. 6, pp. 880-888, 1999. (Pubitemid 30191739)
97. J. Brierley, R. Tsang, W. J. Simpson, M. Gospodarowicz, S. Sutcliffe, and T. Panzarella, "Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control", Thyroid, vol. 6, no. 4, pp. 305-310, 1996. (Pubitemid 26303135)
98. B. D. Rosenbluth, V. Serrano, L. Happersett, et al., "Intensity- modulated radiation therapy for the treatment of nonanaplastic thyroid cancer", International Journal of Radiation Oncology, Biology, Physics, vol. 63, no. 5, pp. 1419-1426, 2005. (Pubitemid 41628037)
99. M. F. Saad, N. G. Ordonez, R. K. Rashid, et al., "Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients", Medicine, vol. 63, no. 6, pp. 319-342, 1984. (Pubitemid 15176708)
100. M. Schlumberger, N. Abdelmoumene, M. J. Delisle, and J. E. Couette, "Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC)", British Journal of Cancer, vol. 71, no. 2, pp. 363-365, 1995.
101. J.-F. Chatal, L. Campion, F. Kraeber-Bodéré, et al., "Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group", Journal of Clinical Oncology, vol. 24, no. 11, pp. 1705-1711, 2006. (Pubitemid 46622142)
102. J. A. Van Heerden, C. S. Grant, H. Gharib, I. D. Hay, and D. M. Ilstrup, "Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma", Annals of Surgery, vol. 212, no. 4, pp. 395-401, 1990. (Pubitemid 20369771)
103. L.-E. Tisell, G. Hansson, S. Jansson, and H. Salander, "Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma", Surgery, vol. 99, no. 1, pp. 60-66, 1986. (Pubitemid 16145521)
104. P. R. Gordon, A. G. Huvos, and E. W. Strong, "Medullary carcinoma of the thyroid gland. A clinicopathologic study of 40 cases", Cancer, vol. 31, no. 4, pp. 915-924, 1973.
105. F. Raue, K. Frank-Raue, and A. Grauer, "Multiple endocrine neoplasia type 2: clinical features and screening", Endocrinology and Metabolism Clinics of North America, vol. 23, no. 1, pp. 137-156, 1994. (Pubitemid 24116801)
106. M. L. Brandi, R. F. Gagel, A. Angeli, et al., "Guidelines for diagnosis and therapy of MEN type 1 and type 2", Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 12, pp. 5658-5671, 2001. (Pubitemid 33152604)
107. Q.-Y. Duh, J. J. Sancho, F. S. Greenspan, et al., "Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy", Archives of Surgery, vol. 124, no. 10, pp. 1206-1210, 1989. (Pubitemid 19250180)
108. Y. Kitamura, K. Shimizu, M. Nagahama, et al., "Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases", Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 11, pp. 4043-4049, 1999. (Pubitemid 30644192)
109. J. A. Fagin, K. Matsuo, A. Karmakar, et al., "High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas", Journal of Clinical Investigation, vol. 91, no. 1, pp. 179-184, 1993. (Pubitemid 23037270)
110. G. Garcia-Rostan, R. L. Camp, A. Herrero, M. L. Carcangiu, D. L. Rimm, and G. Tallini, "β-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis", American Journal of Pathology, vol. 158, no. 3, pp. 987-996, 2001. (Pubitemid 32221790)
111. M. N. Nikiforova, E. T. Kimura, M. Gandhi, et al., "BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas", Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5399-5404, 2003. (Pubitemid 37452745)
112. R. M. Quiros, H. G. Ding, P. Gattuso, R. A. Prinz, and X. Xu, "Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations", Cancer, vol. 103, no. 11, pp. 2261-2268, 2005. (Pubitemid 40686569)
113. G. Tallini, M. Santoro, M. Helie, et al., "RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes", Clinical Cancer Research, vol. 4, no. 2, pp. 287-294, 1998. (Pubitemid 28122740)
114. G. Garcia-Rostan, A. M. Costa, I. Pereira-Castro, et al., "Mutation of the PIK3CA gene in anaplastic thyroid cancer", Cancer Research, vol. 65, no. 22, pp. 10199-10207, 2005. (Pubitemid 41743711)
115. P. Chan, T. Yau, R. Epstein, et al., "Treatment outcomes in anaplastic thyroid carcinoma from 1966-2006: failure of overall survival enhancement despite four decades of progress in surgery, radiotherapy and chemoradiation", Journal of Clinical Oncology, vol. 25, no. 18, supplement, 2007, abstract no. 16537.
116. W. R. Cornett, A. K. Sharma, T. A. Day, et al., "Anaplastic thyroid carcinoma: an overview", Current Oncology Reports, vol. 2, pp. 152-158, 2007. (Pubitemid 46332389)
117. E. Brignardello, M. Gallo, I. Baldi, et al., "Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years", European Journal of Endocrinology, vol. 156, no. 4, pp. 425-430, 2007. (Pubitemid 46672642)
118. K. A. Aldinger, N. A. Samaan, M. Ibanez, and C. S. Hill Jr., "Anaplastic carcinoma of the thyroid. A review of 84 cases of spindle and giant cell carcinoma of the thyroid", Cancer, vol. 41, no. 6, pp. 2267-2275, 1978. (Pubitemid 8370197)
119. J. R. Spires, M. R. Schwartz, and R. H. Miller, "Anaplastic thyroid carcinoma. Association with differentiated thyroid cancer", Archives of Otolaryngology-Head and Neck Surgery, vol. 114, no. 1, pp. 40-44, 1988. (Pubitemid 18031595)
120. Y. S. Venkatesh, N. G. Ordonez, P. N. Schultz, R. C. Hickey, H. Goepfert, and N. A. Samaan, "Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases", Cancer, vol. 66, no. 2, pp. 321-330, 1990. (Pubitemid 20205915)
121. S. I. Sherman, "Thyroid carcinoma", The Lancet, vol. 361, no. 9356, pp. 501-511, 2003. (Pubitemid 36173719)
122. B. Busnardo, O. Daniele, M. R. Pelizzo, et al., "A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients", Journal of Endocrinological Investigation, vol. 23, no. 11, pp. 755-761, 2000. (Pubitemid 32041056)
123. N. Besic, "The role of initial debulking surgery in the management of anaplastic thyroid carcinoma", Surgery, vol. 133, no. 4, pp. 453-455, 2003. (Pubitemid 36515340)
124. E. Kebebew, F. S. Greenspan, O. H. Clark, K. A. Woeber, and A. McMillan, "Anaplastic thyroid carcinoma: treatment outcome and prognostic factors", Cancer, vol. 103, no. 7, pp. 1330-1335, 2005. (Pubitemid 40410726)
125. P. E. Voutilainen, M. Multanen, R. K. Haapiainen, A. K. Leppäniemi, and A. H. Sivula, "Anaplastic thyroid carcinoma survival", World Journal of Surgery, vol. 23, no. 9, pp. 975-979, 1999. (Pubitemid 29398484)
126. P. C. Levendag, P. M. Z. R. De Porre, and W. L. J. Van Putten, "Anaplastic carcinoma of the thyroid gland treated by radiation therapy", International Journal of Radiation Oncology, Biology, Physics, vol. 26, no. 1, pp. 125-128, 1993. (Pubitemid 23137897)
127. G. Mitchell, R. Huddart, and C. Harmer, "Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma", Radiotherapy and Oncology, vol. 50, no. 1, pp. 33-38, 1999. (Pubitemid 29136736)
128. J. Tennvall, E. Tallroth, A. El Hassan, et al., "Anaplastic thyroid carcinoma. Doxorubicin, hyperfractionated radiotherapy and surgery", Acta Oncologica, vol. 29, no. 8, pp. 1025-1028, 1990.
129. S. K. Libutti, "Understanding the role of gender in the incidence of thyroid cancer", Cancer Journal, vol. 11, no. 2, pp. 104-105, 2005. (Pubitemid 44698819)
130. B. Jereb, J. Stjernswärd, and T. Löwhagen, "Anaplastic giant cell carcinoma of the thyroid. A study of treatment and prognosis", Cancer, vol. 35, no. 5, pp. 1293-1295, 1975.
131. I. Sugitani, N. Kasai, Y. Fujimoto, and A. Yanagisawa, "Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid", World Journal of Surgery, vol. 25, no. 5, pp. 617-622, 2001. (Pubitemid 32441436)
132. E. E. W. Cohen, L. S. Rosen, E. E. Vokes, et al., "Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study", Journal of Clinical Oncology, vol. 26, no. 29, pp. 4708-4713, 2008.
133. E. E. Cohen, E. E. Vokes, L. S. Rosen, et al., "A phase II study of axitinib (AG-013736 [AG]) in patients (pts) with advanced thyroid cancers", Journal of Clinical Oncology, vol. 25, no. 18, supplement, 2007, abstract no. 6008.
134. V. Gupta, K. Puttaswamy, W. Lassoued, et al., "Sorafenib targets BRAF and VEGFR in metastatic thyroid carcinoma", Journal of Clinical Oncology, vol. 25, no. 18, supplement, 2007, abstract no. 6019.
135. V. Gupta-Abramson, A. B. Troxel, A. Nellore, et al., "Phase II trial of sorafenib in advanced thyroid cancer", Journal of Clinical Oncology, vol. 26, no. 29, pp. 4714-4719, 2008.
136. S. I. Sherman, M. J. Schlumberger, J. Droz, et al., "Initial results from a phase II trial of motesanib diphosphate (AMG 706) in patients with differentiated thyroid cancer (DTC)", Journal of Clinical Oncology, vol. 25, no. 18, supplement, 2007, abstract no. 6017.
137. E. Mrozek, R. T. Kloos, M. D. Ringel, et al., "Phase II study of celecoxib in metastatic differentiated thyroid carcinoma", Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 6, pp. 2201-2204, 2006. (Pubitemid 43855005)
138. N. A. Pennell, G. H. Daniels, R. I. Haddad, et al., "A phase II study of gefitinib in patients with advanced thyroid cancer", Journal of Clinical Oncology, vol. 25, no. 18, supplement, 2007, abstract no. 6020.
139. M. G. Fury, D. B. Solit, Y. B. Su, et al., "A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors", Cancer Chemotherapy and Pharmacology, vol. 59, no. 4, pp. 467-475, 2007. (Pubitemid 46122325)
140. M. M. Cooney, P. Savvides, S. S. Agarwala, et al., "Phase II study of combretastatin A4 phosphate (CA4P) in patients with advanced anaplastic thyroid carcinoma", Journal of Clinical Oncology, vol. 24, no. 18, supplement, 2006, abstract no. 5580.
141. C. Eng, D. Clayton, I. Schuffenecker, et al., "The relationship between specific ret proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: international RET mutation consortium analysis", Journal of the American Medical Association, vol. 276, no. 19, pp. 1575-1579, 1996. (Pubitemid 26384740)
142. C. Eng, "RET proto-oncogene in the development of human cancer", Journal of Clinical Oncology, vol. 17, no. 1, pp. 380-393, 1999. (Pubitemid 29022417)
143. F. Carlomagno, D. Vitagliano, T. Guida, et al., "ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases", Cancer Research, vol. 62, no. 24, pp. 7284-7290, 2002. (Pubitemid 36025251)
144. S. R. Wedge, D. J. Ogilvie, M. Dukes, et al., "ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration", Cancer Research, vol. 62, no. 16, pp. 4645-4655, 2002.
145. R. S. Herbst, J. V. Heymach, M. S. O'Reilly, A. Onn, and A. J. Ryan, "Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis", Expert Opinion on Investigational Drugs, vol. 16, no. 2, pp. 239-249, 2007. (Pubitemid 46206638)
146. S. A. Wells, J. E. Gosnell, R. F. Gagel, et al., "Vandetanib in metastatic hereditary medullary thyroid cancer: followup results of an open-label phase II trial", Journal of Clinical Oncology, vol. 25, no. 18, supplement, 2007, abstract no. 6018.